Cargando…
VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
Hypoxic zones are common features of metastatic tumors. Due to inactivation of the von Hippel-Lindau gene (VHL), renal cell carcinomas (RCC) show constitutive stabilization of the alpha subunit of the hypoxia-inducible factor (HIF). Thus, RCC represents a model of chronic hypoxia. Development of the...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376471/ https://www.ncbi.nlm.nih.gov/pubmed/30809300 http://dx.doi.org/10.7150/thno.27794 |
_version_ | 1783395565443219456 |
---|---|
author | Ndiaye, Papa Diogop Dufies, Maeva Giuliano, Sandy Douguet, Laetitia Grépin, Renaud Durivault, Jérôme Lenormand, Philippe Glisse, Natacha Mintcheva, Janita Vouret-Craviari, Valérie Mograbi, Baharia Wurmser, Maud Ambrosetti, Damien Rioux-Leclercq, Nathalie Maire, Pascal Pagès, Gilles |
author_facet | Ndiaye, Papa Diogop Dufies, Maeva Giuliano, Sandy Douguet, Laetitia Grépin, Renaud Durivault, Jérôme Lenormand, Philippe Glisse, Natacha Mintcheva, Janita Vouret-Craviari, Valérie Mograbi, Baharia Wurmser, Maud Ambrosetti, Damien Rioux-Leclercq, Nathalie Maire, Pascal Pagès, Gilles |
author_sort | Ndiaye, Papa Diogop |
collection | PubMed |
description | Hypoxic zones are common features of metastatic tumors. Due to inactivation of the von Hippel-Lindau gene (VHL), renal cell carcinomas (RCC) show constitutive stabilization of the alpha subunit of the hypoxia-inducible factor (HIF). Thus, RCC represents a model of chronic hypoxia. Development of the lymphatic network is dependent on vascular endothelial growth factor C (VEGFC) and lies at the front line of metastatic spreading. Here, we addressed the role of VEGFC in RCC aggressiveness and the regulation of its expression in hypoxia. Methods: Transcriptional and post transcriptional regulation of VEGFC expression was evaluated by qPCR and with reporter genes. The involvement of HIF was evaluated using a siRNA approach. Experimental RCC were performed with immuno-competent/deficient mice using human and mouse cells knocked-out for the VEGFC gene by a CRISPR/Cas9 method. The VEGFC axis was analyzed with an online available data base (TCGA) and using an independent cohort of patients. Results: Hypoxia induced VEGFC protein expression but down-regulated VEGFC gene transcription and mRNA stability. Increased proliferation, migration, over-activation of the AKT signaling pathway and enhanced expression of mesenchymal markers characterized VEGFC-/- cells. VEGFC-/- cells did not form tumors in immuno-deficient mice but developed aggressive tumors in immuno-competent mice. These tumors showed down-regulation of markers of activated lymphocytes and M1 macrophages, and up-regulation of M2 macrophages markers and programmed death ligand 1 (PDL1). Over-expression of lymphangiogenic genes including VEGFC was linked to increased disease-free and overall survival in patients with non-metastatic tumors, whereas its over-expression correlated with decreased progression-free and overall survival of metastatic patients. Conclusion: Our study revisited the admitted dogma linking VEGFC to tumor aggressiveness. We conclude that targeting VEGFC for therapy must be considered with caution. |
format | Online Article Text |
id | pubmed-6376471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-63764712019-02-26 VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness Ndiaye, Papa Diogop Dufies, Maeva Giuliano, Sandy Douguet, Laetitia Grépin, Renaud Durivault, Jérôme Lenormand, Philippe Glisse, Natacha Mintcheva, Janita Vouret-Craviari, Valérie Mograbi, Baharia Wurmser, Maud Ambrosetti, Damien Rioux-Leclercq, Nathalie Maire, Pascal Pagès, Gilles Theranostics Research Paper Hypoxic zones are common features of metastatic tumors. Due to inactivation of the von Hippel-Lindau gene (VHL), renal cell carcinomas (RCC) show constitutive stabilization of the alpha subunit of the hypoxia-inducible factor (HIF). Thus, RCC represents a model of chronic hypoxia. Development of the lymphatic network is dependent on vascular endothelial growth factor C (VEGFC) and lies at the front line of metastatic spreading. Here, we addressed the role of VEGFC in RCC aggressiveness and the regulation of its expression in hypoxia. Methods: Transcriptional and post transcriptional regulation of VEGFC expression was evaluated by qPCR and with reporter genes. The involvement of HIF was evaluated using a siRNA approach. Experimental RCC were performed with immuno-competent/deficient mice using human and mouse cells knocked-out for the VEGFC gene by a CRISPR/Cas9 method. The VEGFC axis was analyzed with an online available data base (TCGA) and using an independent cohort of patients. Results: Hypoxia induced VEGFC protein expression but down-regulated VEGFC gene transcription and mRNA stability. Increased proliferation, migration, over-activation of the AKT signaling pathway and enhanced expression of mesenchymal markers characterized VEGFC-/- cells. VEGFC-/- cells did not form tumors in immuno-deficient mice but developed aggressive tumors in immuno-competent mice. These tumors showed down-regulation of markers of activated lymphocytes and M1 macrophages, and up-regulation of M2 macrophages markers and programmed death ligand 1 (PDL1). Over-expression of lymphangiogenic genes including VEGFC was linked to increased disease-free and overall survival in patients with non-metastatic tumors, whereas its over-expression correlated with decreased progression-free and overall survival of metastatic patients. Conclusion: Our study revisited the admitted dogma linking VEGFC to tumor aggressiveness. We conclude that targeting VEGFC for therapy must be considered with caution. Ivyspring International Publisher 2019-01-21 /pmc/articles/PMC6376471/ /pubmed/30809300 http://dx.doi.org/10.7150/thno.27794 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Ndiaye, Papa Diogop Dufies, Maeva Giuliano, Sandy Douguet, Laetitia Grépin, Renaud Durivault, Jérôme Lenormand, Philippe Glisse, Natacha Mintcheva, Janita Vouret-Craviari, Valérie Mograbi, Baharia Wurmser, Maud Ambrosetti, Damien Rioux-Leclercq, Nathalie Maire, Pascal Pagès, Gilles VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness |
title | VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness |
title_full | VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness |
title_fullStr | VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness |
title_full_unstemmed | VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness |
title_short | VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness |
title_sort | vegfc acts as a double-edged sword in renal cell carcinoma aggressiveness |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376471/ https://www.ncbi.nlm.nih.gov/pubmed/30809300 http://dx.doi.org/10.7150/thno.27794 |
work_keys_str_mv | AT ndiayepapadiogop vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT dufiesmaeva vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT giulianosandy vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT douguetlaetitia vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT grepinrenaud vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT durivaultjerome vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT lenormandphilippe vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT glissenatacha vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT mintchevajanita vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT vouretcraviarivalerie vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT mograbibaharia vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT wurmsermaud vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT ambrosettidamien vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT riouxleclercqnathalie vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT mairepascal vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness AT pagesgilles vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness |